Volume 10 Issue 39
Published - 14:00 UTC 08:00 EST 8-Feb-2008 
Next Update - 14:00 UTC 08:00 EST 9-Feb-2008

Editor: Susan K. Boyer, RN
© RAmEx Ars Medica,Inc.
All rights reserved.


   

 




What is menkes disease? 

(8 February 2008: VIDYYA MEDICAL NEWS SERVICE) -- Menkes Disease is caused by a defective gene that regulates the metabolism of copper in the body. Because it is an X-linked gene, the disease primarily affects male infants. Copper accumulates at abnormally low levels in the liver and brain, but at higher than normal levels in the kidney and intestinal lining. Affected infants may be born prematurely. Symptoms appear during infancy. Normal or slightly slowed development may proceed for 2 to 3 months, and then there will be severe developmental delay and a loss of early developmental skills. Menkes Disease is also characterized by seizures, failure to thrive, subnormal body temperature, and strikingly peculiar hair, which is kinky, colorless or steel-colored, and easily broken. There can be extensive neurodegeneration in the gray matter of the brain. Arteries in the brain can also be twisted with frayed and split inner walls. This can lead to rupture or blockage of the arteries. Weakened bones (osteoporosis) may result in fractures.

Is there any treatment?

Early treatment with subcutaneous (under the skin) or intravenous (in a vein) injections of copper supplements may be of some benefit. Other treatment is symptomatic and supportive.

What is the prognosis?

The prognosis for individuals with Menkes disease is poor. Most children with Menkes Disease die within the first decade of life.

What research is being done?

The NINDS supports research on gene-linked neurodegenerative disorders such as Menkes Disease. The goals of this research are to increase scientific understanding of these disorders and to find ways to prevent, treat, and cure them.

Organizations

National Organization for Rare Disorders (NORD)
P.O. Box 1968
(55 Kenosia Avenue)
Danbury, CT 06813-1968
orphan@rarediseases.org
http://www.rarediseases.org
Tel: 203-744-0100 Voice Mail 800-999-NORD (6673)
Fax: 203-798-2291

Return to Vidyya Medical News Service for 8 February 2008

© RAmEx Ars Medica,Inc. All rights reserved. Information appearing on the Vidyya Medical News Service is not intended as a substitute for professional medical care. Seek professional medical help and follow your health care provider's advice.